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Ewing’s Sarcoma (EWS), is a member of the Ewing 
sarcoma family of tumours (ESFT); a group of small 
round blue cell neoplasms. It arises frequently from 
long bones but its origin from non-sacral spine is to a 
great degree uncommon, representing only 0.9% of all 
the cases with amazingly rare association of cervical 
spine.1,2 Its peak incidence is in the second decade of 
life with slight male 
predominance.2 Local pain, the most common 
symptom, is followed by a palpable swelling. 
Neurological deficit produced by spinal cord 
compression is often a delayed presentation.1 
Adequate multimodality treatment, comprising of 
surgery, chemotherapy and radiotherapy, is aimed for 
cure rather than palliation whenever possible.3 
To date, the number of reported cases of EWS with 
primary localization in lumbar and cervical segments 
of the spine remains small, with cervical spine being 
reported extremely rarely. This is also one of the 
reasons why there are still several concerns about the 
optimal treatment.4,5 
We report this rare lesion in a 16 years old male who 
presented with a progressively increasing posterior 
cervical swelling, local pain and dysphagia to solids. 
 
Case Report 
A 16 year old male came to our attention due to a 
progressively increasing painful swelling in posterior 
cervical region, over a period of three months. 
Swelling was gradual in onset and was associated with 
fever, vomiting and odynophagia. Family history was 
unremarkable. General physical examination showed a 
young boy of medium built, oriented in time, place 
and person, vitally stable and with GCS of 15/15. 
Examination of head and neck revealed a tender, firm, 
immobile swelling measuring 13 × 8 cm over the 
posterior cervical region. Swelling was not adherent to 
the skin and overlying skin changes were 
unremarkable. His sensory and motor system was 
intact.  
On ultrasonography, a mixed echogenicity mass of 
about 2.9 × 2.0 cm was seen in the occipital region. The 
lesion showed no definite flow on colour Doppler. Fine 
needle aspiration of the swelling was done which 
revealed high cellularity smears composed of a large 
population of histiocytes, neutrophils and a few 
lymphocytes. Contrast enhanced computed 
tomography (CECT) scan showed enlargement and a 
mixed lytic and sclerotic lesion with moth eaten 
appearance of C1 vertebra and lateral elements of C2 
vertebra. Mass was seen extending in the right 
parapharyngeal space causing compression of 
oropharyngeal and nasopharyngeal air column. 
Extradural component was seen on the left side 
causing slight narrowing of cervical canal. Magnetic 
resonance imaging (MRI) revealed diffuse soft tissue 
intensity in the paraspinous region surrounding the 
upper cervical spine.  
During the workup phase patient was managed 
conservatively with a neck collar and analgesics. 
Decompression laminectomy and partial excision of 
tumour was done. The patient had histologic 
confirmation of EWS. Histopathology revealed small 
round blue cells with hyperchromatic pleomorphic 
nuclei having high nucleus/cytoplasm ratio and clear 
cytoplasm. Immunohistochemistry showed positive 
CD-99, FLI-1 was focal weak positive and negative 
NSE (Neuron Specific Enolase) and Tdt (Terminal 
deoxynucleotidyltransferase). Post operative recovery 
was uneventful. Patient’s symptoms improved and he 
was started on a course of chemotherapy and radiation 
therapy prior to discharge. 
 
Discussion 
James Ewing, first described Ewing's sarcoma in 1920. 
This distinctive, small, round cell sarcoma is a highly 
malignant neoplasm representing the fourth most 
common bone tumor overall6, but the second most 
common basic essential bone tumour in youth and 
puberty with 75% emergence in patients under 20 
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years and a slight male transcendence (1.6:1).2 
Likewise, our patient was a 16 year old male. 
It arises commonly in the long bones (47%), pelvis 
(19%), or ribs (12%).3 Ewing's sarcoma of spine records 
for just 3.5% to 14.9% of all essential bone sarcomas 
with extremely rare involvement of cervical spine.3,7 
However, C1 and C2 vertebral lesions were involved 
in our patient while rest of the spine was spared. 
In 90% of cases, Ewing’s sarcoma family tumour 
(ESFT) cells harbour the translocation 
t(11;22)(q24;q12), and in the remaining 10% the variant 
translocation is t(21;12)(22;12).8 No hereditary or 
congenital syndromes, environmental or known risk 
factors have been associated with the occurrence of 
EWS.9   No such triggering component was found in 
our patient.  
It appears with a clinical triad of local pain, 
neurological deficit, and a palpable mass.10 The 
characteristics of pain in our patient were similar to 
the ones reported in other cases but our patient 
differed from other reported cases due to the fact that 
there was no neurological deficit. 
Ewing sarcoma is made out of sheets of little round 
blue cells with high nuclear to cytoplasmic proportion, 
round nuclei with finely scattered chromatin and 
sparse eosinophilic cytoplasm. Rare rosette 
development is likewise seen.7 Similar histological 
findings were found in our patient. 
Immunohistochemistry is key as the group of little 
round cell tumours is somewhat extensive and 
incorporates synovial sarcoma, osteosarcoma, 
melanoma, malignant peripheral nerve sheath tumour 
and numerous other tumours. ESFT cells show 
membranous articulation of CD99 or MIC2, 
synaptophysin, neuron-particular enolase (NSE), and 
S-100 protein on immunohistochemistry. Antibody 
against FLI1, which is focused in the core of the tumor 
cells, appears to be particular for EFT.7 Along these 
lines, immunohistochemistry was done for making 
provisional diagnosis in our patient which 
demonstrated positive CD-99 and positive FLI-1 while 
negative NSE and Tdt. 
Plain radiographic indications of EWS are late to show 
up. The most widely recognized finding, being 
accounted for in our patient also, is lytic bone 
destruction which ranges from focal lytic lesion to total 
flattening of the vertebral body. Sclerotic changes, 
being reported in our patient, are seldom seen.3 CT is 
of immense importance in deciding the degree of 
spread of tumour. However, MRI is better than CT for 
envisioning epidural pressure, tumour spread and 
relationship to contiguous vasculature.3 In perspective 
of aforementioned points of interest, MRI was 
performed in our patient along with CT. 
Holland et al reported that if the mass is not producing 
a quick dynamic neurologic change, an argument may 
be made to initially continue with a needle biopsy and 
feasible preoperative chemotherapy, causing the 
tumor to shrink and making gross total resection 
easier, trailed by radiotherapy. However, if a quickly 
developing mass is creating progressively increasing 
neurologic deficit, then the primary objective of 
operation is decompression of the spinal cord with the 
proposed laminectomy.5 Postoperative chemotherapy 
is essential to decrease the rate of recurrence and 
metastasis and to lengthen the survival time. 
However, radiotherapy is ought to be utilized with 
alertness, as the spinal cord is susceptible to radiation; 
thus, local irradiation is suggested.11 Likewise, in our 
patient, preoperative chemotherapy followed by 
decompressive laminectomy along with subtotal 
resection of tumour was performed which was later 
trailed by radiotherapy. 
The prognosis of Ewing's sarcoma is poorer in the 
cervical spine as compared to that in the thoracic and 
lumbosacral locales. A high rate of metastasis has been 
accounted for due to the troublesome en block 
removal of tumour in the cervical spine.11 Poor 
prognostic components incorporate tumour ≥8 cm, 
pelvic primary, metastases and age >15 years at the 
time of diagnosis.9 Based on above mentioned facts, 
prognosis in our patient is relied upon to be good as 
metastatic work up was negative. Penget et al12 
demonstrated a change in the 3-year recurrence free 
survival from 18% with single modality treatment to 
46% with multimodality treatment. Our patient, 
receiving multidisciplinary treatment, had no 
manifestation up to three months of follow-up. 
 
Figure I 
 
(L) Firm, immobile swelling measuring 13 × 8 cm. 
(R) Contrast enhanced Computed Tomography 
(CECT) scan revealing moth eaten appearance of C1 
and C2 vertebra. 
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Figure II 
 
Histopathology revealing small round blue cells with 
hyperchromatic pleomorphic nuclei having high 
nucleus/cytoplasm ratio and clear cytoplasm. 
 
Conclusion 
The physician should be alert to the possibility of 
spinal malignancy in the patient belonging to the first 
two decades of life having symptom of severe local 
pain with normal X-ray which may guide towards 
serious but treatable condition such as Ewing’s 
sarcoma. However, detailed patient history, careful 
physical examination and appropriate imaging are of 
paramount importance in the diagnosis of this rare 
disease. 
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